Understand weight-loss peptides. Then source them with confidence.

Research peptides sold for laboratory use sit in a regulatory gray area in most jurisdictions. Some compounds discussed here, including semaglutide and tirzepatide, also exist as FDA-approved prescription drugs sold only through pharmacies. Nothing on this site is intended for human use, self-administration, or as medical advice.

It means the compound is sold for laboratory research, not for consumption. It has not been evaluated by the FDA for safety or effectiveness in humans through this sourcing channel, even if an approved analog exists elsewhere.

Each added receptor pathway (GIP, then glucagon) changes the biology being studied, not just the strength of the effect. See the mechanism comparison above for a breakdown by compound.

Lyophilized (freeze-dried) peptides are generally more stable than peptides in solution, which is why they ship as powder. Suppliers typically recommend cold, dark, dry storage; always follow the storage terms printed on the certificate of analysis or product label. This site does not give preparation or handling protocols.

No. This site is an independent research and comparison resource. We link out to Core Power Peptides and American Peptides, two research-peptide suppliers whose published quality claims we summarize but have not independently verified, and we may earn a commission on purchases made through those links at no extra cost to you. See our affiliate disclosure below.

Import regulations for research chemicals vary widely by country and change often. Check your local laws before placing an order from any source.

A peptide is a short chain of amino acids, like semaglutide or retatrutide, and generally cannot survive digestion, which is why peptide-class compounds are typically injectable. A small-molecule agonist, like orforglipron or 5-Amino-1MQ, reaches the same or a related receptor through a chemically different, non-peptide structure that can often be taken orally.

Approval status reflects how far a specific formulation has moved through regulatory review for human prescription use, not how much research exists on the underlying receptor pathway. A compound can be well studied in research settings while still sitting in preclinical or clinical-trial status, and an approved analog existing elsewhere does not change the research-only sourcing channel discussed on this site.

It confirms that a lab independent of the manufacturer, not the seller grading its own product, ran purity and identity testing (typically HPLC for purity and mass spectrometry for molecular identity) on that specific batch. In-house-only testing is not equivalent, since it carries no independent check on the result.

The compound name is just a label for a specific molecule; the receptor pathway is what determines the biology being studied. Two compounds with very different names can share a mechanism, and two compounds that sound similar can target entirely different receptors, which is why this site organizes profiles by mechanism class (GLP-1, dual agonist, triple agonist, and so on) rather than alphabetically.